156 related articles for article (PubMed ID: 9813111)
1. Role of p300, a transcriptional coactivator, in signalling of TGF-beta.
Nishihara A; Hanai JI; Okamoto N; Yanagisawa J; Kato S; Miyazono K; Kawabata M
Genes Cells; 1998 Sep; 3(9):613-23. PubMed ID: 9813111
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.
Shen X; Hu PP; Liberati NT; Datto MB; Frederick JP; Wang XF
Mol Biol Cell; 1998 Dec; 9(12):3309-19. PubMed ID: 9843571
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
Feng XH; Zhang Y; Wu RY; Derynck R
Genes Dev; 1998 Jul; 12(14):2153-63. PubMed ID: 9679060
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
[TBL] [Abstract][Full Text] [Related]
6. E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins.
Nishihara A; Hanai J; Imamura T; Miyazono K; Kawabata M
J Biol Chem; 1999 Oct; 274(40):28716-23. PubMed ID: 10497242
[TBL] [Abstract][Full Text] [Related]
7. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
Ghosh AK; Yuan W; Mori Y; Varga J
Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
9. Physical and functional interaction of SMADs and p300/CBP.
Pouponnot C; Jayaraman L; Massagué J
J Biol Chem; 1998 Sep; 273(36):22865-8. PubMed ID: 9722503
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
11. The Smad3 linker region contains a transcriptional activation domain.
Wang G; Long J; Matsuura I; He D; Liu F
Biochem J; 2005 Feb; 386(Pt 1):29-34. PubMed ID: 15588252
[TBL] [Abstract][Full Text] [Related]
12. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment.
Furumatsu T; Tsuda M; Taniguchi N; Tajima Y; Asahara H
J Biol Chem; 2005 Mar; 280(9):8343-50. PubMed ID: 15623506
[TBL] [Abstract][Full Text] [Related]
13. Intracellular signaling of the TGF-beta superfamily by Smad proteins.
Kawabata M; Imamura T; Inoue H; Hanai J; Nishihara A; Hanyu A; Takase M; Ishidou Y; Udagawa Y; Oeda E; Goto D; Yagi K; Kato M; Miyazono K
Ann N Y Acad Sci; 1999; 886():73-82. PubMed ID: 10667205
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
15. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells.
Ghosh AK; Bhattacharyya S; Varga J
J Biol Chem; 2004 Nov; 279(46):47455-63. PubMed ID: 15345715
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.
Janknecht R; Wells NJ; Hunter T
Genes Dev; 1998 Jul; 12(14):2114-9. PubMed ID: 9679056
[TBL] [Abstract][Full Text] [Related]
20. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
